- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04036708
Caregiver Training to Prevent Konzo Disease in Children in Democratic Republic of Congo (DRC)
March 29, 2024 updated by: Michael J. Boivin, Michigan State University
Caregiver Early Child Development Training for Preventing Konzo From Toxic Cassava in the Democratic Republic of Congo (DRC)
The proposed research adapted the caregiver training and child neurodevelopmental assessment capacity that the PI previously built in Uganda beginning in 2008, to a community-based intervention model for the prevention of konzo in the Democratic Republic of Congo.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Early childhood (1 through 4 yrs) is a period of dramatic developmental change that can be seriously compromised by exposure to toxic cyanogenic cassava (konzo disease), with potentially great impact throughout central and western sub-Sahara Africa in regions dependent on this food staple.
In the face of ongoing economic instability and nutritional, medical and educational deprivation affecting konzo at-risk communities in the Democratic Republic of Congo, no programs exist for sustaining a favorable developmental milieu for these children.
By establishing the viability of caregiver training interventions to enhance functionality among caregivers and improve caregiving quality while preventing konzo, this research l can benefit tens of millions of children at-risk neurodevelopmentally; not only from poorly processed cyanogenic cassava, but also from a myriad of other non-infectious and infectious diseases.
Study Type
Interventional
Enrollment (Actual)
238
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Michael J Boivin, PhD
- Phone Number: (517) 884-0281
- Email: boivin@msu.edu
Study Contact Backup
- Name: Itziar Familiar-Lopez, PhD
- Phone Number: (517) 884-2906
- Email: familiar@msu.edu
Study Locations
-
-
-
Kinshasa, Congo, The Democratic Republic of the
- Institute National of Research National (INRB)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 4 years (Child)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Mother with at least one child aged between 1 and 4 years
- Mother is the primary caregiver of child
- Mother is 18 years of age or older
Exclusion Criteria:
- History of brain injury (infectious, traumatic, birth) in child
- Konzo disease in any family member of household
- Epilepsy in child
- Any neurodisability in child
- Caregiver is unable to participate in the year-long training
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: MISC and WTM
Wetting method (WTM)+ Mediational Intervention for Sensitizing Caregivers (MISC) bi-weekly for 12 months.
|
The wetting method is an evidence-based, simple process to remove cyanogens from cassava flour.
It involves teaching women to add water to cassava flour and allow it to stand for 2 h in the sun or 5 h in the shade for the hydrogen cyanide gas to escape.
Colorfully illustrated and durable laminated posters depicting the WTM were distributed to participating households.
Women received this training bi-weekly for 12 months.
The study team used MISC to train DRC mothers in practical day-to-day activities with their children to enhance 5 key mediational processes: 1) focusing (getting the child's attention and engaging directing them to learning experiences); 2) exciting (communicating excitement, appreciation, and affection with the learning experience); 3) expanding (making the child aware of how the learning experience transcends the present situation and can include past and future issues beyond the immediate need of the moment); 4) encouraging (emotional support to foster the child's sense of security and competence); and 5) regulating (helping to direct the child's behavior in constructive ways with a goal towards self-regulation).
|
Active Comparator: WTM only
WTM trainings only (recommended standard of care) bi-weekly for 12 months.
|
The wetting method is an evidence-based, simple process to remove cyanogens from cassava flour.
It involves teaching women to add water to cassava flour and allow it to stand for 2 h in the sun or 5 h in the shade for the hydrogen cyanide gas to escape.
Colorfully illustrated and durable laminated posters depicting the WTM were distributed to participating households.
Women received this training bi-weekly for 12 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mullen Scales of Early Learning (MSEL) Composite Score
Time Frame: Month 6, month 12
|
The Mullen Scales of Early Learning (MSEL) assesses child developmental domains: visual reception, gross motor skills, fine motor skills, receptive language, and expressive language.
A composite t-score derived from standardized t-scores of the four domains (excluding gross motor) provides a measure of g, the general measure of fluid intelligence thought to underlie general cognitive ability.
The composite t-score ranges from 40 to 130.
The t-scores have mean 100 and standard deviation 15 in the Western population.
Higher scores reflect better outcome.
Measure is applicable to children only, not collected from caregivers
|
Month 6, month 12
|
Child Urine Thiocyanite Level
Time Frame: Month 6, month 12
|
Technicians collected samples of urine on the same day as child assessments, so that they are contiguous with level of cyanide exposure from current poorly processed cassava.
Urine thiocyanite levels in urine were measured in micromol per liter.
The range was 0-1032, higher scores reflect worse outcome.
Data collected from children only, not collected from caregivers.
|
Month 6, month 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Home Observation for the Measurement of the Environment (HOME) Score
Time Frame: Month 6, month 12
|
Home Observation for the Measurement of the Environment (HOME) composite measure designed to assess the quality and quantity of stimulation that the child is exposed to in their home environment.
The Infant/Toddler version includes 45 items answered on the scale from 0=none to 3=good.
A total HOME score was generated by summing item responses.
Potential range is 0 to 135.
Higher HOME scores indicate higher quality of home environment.
Measure applies to children only.
|
Month 6, month 12
|
Child Physical Growth: Length for Age Z-score
Time Frame: Month 6, month 12
|
Length for age z-score was determined using the World Health Organization algorithm using child's length, sex, and age at the time of measurement.
The world population mean is 0 with standard deviation 1. Z-scores of -2 or below are often used to indicate stunting.
|
Month 6, month 12
|
Child Physical Growth: Weight for Age Z-score
Time Frame: Month 6, month 12
|
Weight for age z-score was determined using the World Health Organization algorithm using child's length, sex, and age at the time of measurement.
The world population mean is 0 with standard deviation 1.
|
Month 6, month 12
|
Caregiver Anxiety Symptoms
Time Frame: Month 6, month 12
|
The modified Hopkins Symptom Checklist was used to assess caregiver anxiety.
The instrument included 9 yes/no items, and the item responses were summed into the total score.
The potential range was 0-9 with higher score indicating worse anxiety.
Measure applicable to caregiver only.
Data were not collected from children.
|
Month 6, month 12
|
Caregiver Depressive Symptoms
Time Frame: Month 6, month 12
|
The modified Hopkins Symptom Checklist was used to assess caregiver depressive symptoms.
The instrument included 9 yes/no items, and the item responses were summed into the total score.
The potential range was 0-9 with higher score indicating worse depressive symptoms.
Measure applies to caregivers only, data were not collected from children.
|
Month 6, month 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Michael J Boivin, PhD, Professor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Tshala-Katumbay D, Mumba N, Okitundu L, Kazadi K, Banea M, Tylleskar T, Boivin M, Muyembe-Tamfum JJ. Cassava food toxins, konzo disease, and neurodegeneration in sub-Sahara Africans. Neurology. 2013 Mar 5;80(10):949-51. doi: 10.1212/WNL.0b013e3182840b81.
- Boivin MJ, Okitundu D, Makila-Mabe B, Sombo MT, Mumba D, Sikorskii A, Mayambu B, Tshala-Katumbay D. Cognitive and motor performance in Congolese children with konzo during 4 years of follow-up: a longitudinal analysis. Lancet Glob Health. 2017 Sep;5(9):e936-e947. doi: 10.1016/S2214-109X(17)30267-X.
- Boivin MJ, Okitundu D, Makila-Mabe Bumoko G, Sombo MT, Mumba D, Tylleskar T, Page CF, Tamfum Muyembe JJ, Tshala-Katumbay D. Neuropsychological effects of konzo: a neuromotor disease associated with poorly processed cassava. Pediatrics. 2013 Apr;131(4):e1231-9. doi: 10.1542/peds.2012-3011. Epub 2013 Mar 25.
- Kashala-Abotnes E, Sombo MT, Okitundu DL, Kunyu M, Bumoko Makila-Mabe G, Tylleskar T, Sikorskii A, Banea JP, Mumba Ngoyi D, Tshala-Katumbay D, Boivin MJ. Dietary cyanogen exposure and early child neurodevelopment: An observational study from the Democratic Republic of Congo. PLoS One. 2018 Apr 17;13(4):e0193261. doi: 10.1371/journal.pone.0193261. eCollection 2018.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2021
Primary Completion (Actual)
August 31, 2022
Study Completion (Actual)
August 31, 2022
Study Registration Dates
First Submitted
July 23, 2019
First Submitted That Met QC Criteria
July 25, 2019
First Posted (Actual)
July 30, 2019
Study Record Updates
Last Update Posted (Actual)
April 24, 2024
Last Update Submitted That Met QC Criteria
March 29, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2272
- R21HD098588 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The study coordinator assigns a unique identification number to each research subject at entry into the study.
The first page of the risk-factor questionnaire, which contains identifying information, names and addresses, is removed after data entry and stored at the field office in a locked file dedicated to this research study.
The data files will include only study numbers, which are linked through a security system to a named file maintained for the purpose of informing individuals of information pertinent to their health.
The name file is only accessible to the PI Professor Michael Boivin.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malnutrition
-
HAN University of Applied SciencesFrieslandCampina; HAS Hogeschool; Centre of Expertise Food (CoE Food); SligroCompletedMalnutrition; Protein | Protein MalnutritionNetherlands
-
International Centre for Diarrhoeal Disease Research...GlaxoSmithKline; Stanford UniversityCompletedMalnutrition | Malnutrition in Children | Child MalnutritionBangladesh
-
University of Nove de JulhoUnknownMalnutrition, ChildBrazil
-
International Centre for Diarrhoeal Disease Research...UNICEFNot yet recruitingMalnutrition SevereBangladesh
-
UNICEFSave the ChildrenCompletedSevere MalnutritionCongo, The Democratic Republic of the
-
University of Erlangen-Nürnberg Medical SchoolPfrimmer Nutricia GmbH, Erlangen , GermanyCompletedNursing Home Residents | Malnutrition or Risk of MalnutritionGermany
-
Aga Khan UniversityAction Contre la FaimCompletedEvaluation of the Effectiveness and Impact of Community Case Management of Severe Acute MalnutritionSevere MalnutritionPakistan
-
Action Against Hunger USAUniversity of Washington; Ethiopian Public Health InstituteNot yet recruitingModerate Acute Malnutrition | Severe Acute Malnutrition
-
Academy of Nutrition and DieteticsHartford Hospital; University of New Mexico; Meals on Wheels Central TexasNot yet recruiting
-
Diego MorettiSwiss Federal Institute of Technology; Wageningen University and Research; St... and other collaboratorsCompletedMalnutrition; ProteinSwitzerland
Clinical Trials on Wetting method (WTM)
-
Montreal Heart InstituteNational Health and Medical Research Council, AustraliaCompletedCoronary Artery DiseaseCanada
-
Johnson & Johnson Vision Care, Inc.CompletedAstigmatismUnited States
-
Ministry of Public Health, Democratic Republic...National Institutes of Health (NIH); Oregon Health and Science University; National... and other collaboratorsCompletedNeurotoxicity Syndrome, Cassava | Neurotoxicity Syndrome, Cyanate | Neurotoxicity Syndrome, Cyanide | Neurotoxicity Syndrome, ThiocyanateCongo, The Democratic Republic of the
-
University of North Carolina, Chapel HillWithdrawn
-
Istanbul UniversityRecruitingAmelogenesis Imperfecta | Dental Age EstimationTurkey
-
Firat UniversityNot yet recruitingPain | Child Development | Nursing CareTurkey
-
JSI Research & Training Institute, Inc.UnknownWasting | Severe Acute Malnutrition
-
Dr. Behcet Uz Children's HospitalRecruitingAcute Respiratory Distress Syndrome | Acute Respiratory Failure | Pediatric Acute Respiratory Distress Syndrome (PARDS)Turkey
-
Indonesia UniversityCompletedPremature | Feeding; Difficult, NewbornIndonesia
-
Assistance Publique - Hôpitaux de ParisURC-ECO Clinical trial unit on health Economics, Hotel-Dieu Hospital; EA 7334...Unknown